DGX
Quest Diagnostics, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$247.06
−1.50%Forward multiples
Based on analyst estimates
- P/E forward
- 21.29x
- P/E 2026E
- 22.21x
- P/E 2027E
- 20.96x
- P/E 2028E
- 19.23x
- P/S forward
- 2.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.27x
- PEG TTM
- 1.76x
- Price / book
- 3.56x
- Price / sales
- 2.30x
- Price / cash flow
- 13.93x
Enterprise value
- Enterprise value
- $33.1B
- EV / sales
- 2.79x
- EV / EBITDA
- 14.36x
- EV / EBIT
- 19.13x
- Market cap
- $27.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026